Digital Support for Multiple Myeloma Quality of Life
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCareAcross
About this trial
The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform.
Specifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.
Eligibility criteria
Qualifiers
Adult patients with newly diagnosed or relapsed/refractory multiple myeloma
Patients that are able to use the digital platform/application
Disqualifiers
Patients that are not able to use the digital platform/application
Trial design
Treatments tested in this trial
- Digital support
Treatment groups
108 Participants
are divided into 2 treatment groupsLocations
1Alexandra General Hospital11528, Athens Greece
Sponsors and collaborators
CareAcross
Lead sponsor
Μedical Association for the Study of Cancer Biology and Treatments (Μ.Α.S.CA.B.T.)
Collaborator
Source ClinicalTrials.gov